Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Employment test 51 - 200 employees
Company dna mathys and squire llp
no operation time available
Headquarter in London and 5 offices
active in Legal Services and Matchmaking and Trading

We have observed 2 EP applications David John Martin has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 18, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13723136

COMBINATION OF CD37 ANTIBODIES WITH FURTHER AGENTS

IPC classification:
A61K 31/4184, A61K 39/395, A61P 35/02, C07K 16/28
Applicant:
Boehringer Ingelheim International GmbH
Agent:
David John Martin, Boehringer Ingelheim GmbH
Status:
EXAMINATION IN PROGRESS
EP13723498

COMBINATION OF CD37 ANTIBODIES WITH ICE (IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE)

IPC classification:
A61K 39/395, A61P 35/02, C07K 16/28
Applicant:
Boehringer Ingelheim International GmbH
Agent:
David John Martin, Boehringer Ingelheim GmbH
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature